These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1414270
1. Biological markers and the cholinergic hypothesis in Alzheimer's disease. Nordberg A. Acta Neurol Scand Suppl; 1992; 139():54-8. PubMed ID: 1414270 [No Abstract] [Full Text] [Related]
2. Cholinergic markers in the early diagnosis of Alzheimer's disease. Jenden DJ. Bull Clin Neurosci; 1985; 50():49-52. PubMed ID: 3915951 [No Abstract] [Full Text] [Related]
3. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. DeKosky ST, Scheff SW, Markesbery WR. Neurology; 1985 Oct; 35(10):1425-31. PubMed ID: 4033925 [Abstract] [Full Text] [Related]
4. Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion. Gu Z, Yu J, Perez-Polo JR. Brain Res; 1998 Aug 10; 801(1-2):190-7. PubMed ID: 9729378 [Abstract] [Full Text] [Related]
5. Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex. Mesulam MM, Geula C. Brain Res; 1992 Apr 10; 577(1):112-20. PubMed ID: 1521137 [Abstract] [Full Text] [Related]
6. Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits? King RG. Med Hypotheses; 1984 Jul 10; 14(3):301-6. PubMed ID: 6472159 [Abstract] [Full Text] [Related]
7. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease. Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR. Ann Neurol; 1992 Jun 10; 31(6):611-20. PubMed ID: 1355334 [Abstract] [Full Text] [Related]
9. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. Mesulam MM, Geula C. J Comp Neurol; 1988 Sep 08; 275(2):216-40. PubMed ID: 3220975 [Abstract] [Full Text] [Related]
10. The cholinergic system in Alzheimer's disease. Kása P, Rakonczay Z, Gulya K. Prog Neurobiol; 1997 Aug 08; 52(6):511-35. PubMed ID: 9316159 [Abstract] [Full Text] [Related]
11. Abnormalities in the central cholinergic transmitter system of the genetically epilepsy-prone rat. Laird HE, Hadjiconstantinou M, Neff NH. Life Sci; 1986 Sep 01; 39(9):783-7. PubMed ID: 3018414 [Abstract] [Full Text] [Related]
12. Convergent cholinergic activities in aging and Alzheimer's disease. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. Neurobiol Aging; 1992 Sep 01; 13(3):393-400. PubMed ID: 1625768 [Abstract] [Full Text] [Related]
13. The localization of central cholinergic neurons. Vincent SR, Satoh K, Fibiger HC. Prog Neuropsychopharmacol Biol Psychiatry; 1986 Sep 01; 10(3-5):637-56. PubMed ID: 3541055 [Abstract] [Full Text] [Related]
14. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease. Foster NL, Tamminga CA, O'Donohue TL, Tanimoto K, Bird ED, Chase TN. Neurosci Lett; 1986 Jan 02; 63(1):71-5. PubMed ID: 3754039 [Abstract] [Full Text] [Related]
15. Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease. Lehéricy S, Hirsch EC, Cervera P, Hersh LB, Hauw JJ, Ruberg M, Agid Y. Proc Natl Acad Sci U S A; 1989 Nov 02; 86(21):8580-4. PubMed ID: 2682652 [Abstract] [Full Text] [Related]
16. Bilateral symmetry of cholinergic deficits in Alzheimer's disease. Zubenko GS, Moossy J, Hanin I, Martinez AJ, Rao GR, Kopp U. Arch Neurol; 1988 Mar 02; 45(3):255-9. PubMed ID: 3341949 [Abstract] [Full Text] [Related]
17. Heterogeneity of postnatal development of ACh levels in brain regions of the mouse. Sawa A, Stavinoha WB. Brain Res; 1987 Jul 02; 431(1):151-5. PubMed ID: 3620984 [Abstract] [Full Text] [Related]
18. The cholinergic system in old age and Alzheimer's disease. Perry EK. Age Ageing; 1980 Feb 02; 9(1):1-8. PubMed ID: 7361631 [Abstract] [Full Text] [Related]
19. Cortical cholinergic markers in schizophrenia. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL. Schizophr Res; 1994 May 02; 12(2):137-44. PubMed ID: 8043524 [Abstract] [Full Text] [Related]
20. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase. Fu AL, Li Q, Dong ZH, Huang SJ, Wang YX, Sun MJ. Neurosci Lett; 2004 Sep 30; 368(3):258-62. PubMed ID: 15364407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]